Identifying Circulating and Lung Tissue Cytokines Associated with Thoracic Irradiation and AEOL 10150 Treatment in a Nonhuman Primate Model
- 30 April 2020
- journal article
- research article
- Published by Radiation Research Society in Radiation Research
- Vol. 194 (1), 81-88
- https://doi.org/10.1667/rr14310.1
Abstract
Inflammatory cytokines have been suggested to play important roles in radiation-induced lung injury (RILI). Identifying significantly changed circulating and tissue cytokines after thoracic irradiation will aid in deciphering the mechanism of RILI and identifying potential biomarkers to predict clinical outcome. Herein, the levels of 24 cytokines were measured in serial plasma samples and lung tissue samples collected from a pilot study where nonhuman primates (NHPs) received 11.5 Gy whole thoracic lung irradiation (WTLI) and were then treated with or without a medical countermeasure, AEOL 10150 [a superoxide dismutase (SOD) mimetic]. Seven plasma cytokines (i.e., IP-10, MCP-1, IL-12, IL-15, IL-16, IL-7 and IL-6) were found to be significantly changed at different time points due to WTLI. Plasma IP-10 and MDC were significantly changed between the vehicle group and the drug group. The levels of IP-10, MCP-1, MIP-1α, TARC, IL-17, TNF-β and IL-6 were significantly elevated in the lung tissue lysates of NHPs that received WTLI versus radiation-naïve NHPs. The terminal plasma concentrations of IP-10, MDC, TARC, IL-12, IL-15 and IL-6 were significantly correlated with their levels in the lung tissue. The levels of four cytokines (MCP-4, IL-17, TNF-β and IL-2) at early time points (≤8 weeks postirradiation) were significantly correlated with their terminal plasma levels, respectively. Statistical analysis indicated that circulating cytokines could be discriminatory predictors of AEOL 10150 treatment. Taken together, our data suggested that the cytokine profiles were significantly changed after WTLI as well as mitigator treatment, and that the plasma cytokine profiles could potentially be used to distinguish vehicle or mitigator treatment after WTLI in a NHP model.Keywords
This publication has 26 references indexed in Scilit:
- Combining Physical and Biologic Parameters to Predict Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Radiation damage to the lung: Mitigation by angiotensin‐converting enzyme (ACE) inhibitorsRespirology, 2011
- A Further Comparison of Pathologies after Thoracic Irradiation among Different Mouse Strains: Finding the Best Preclinical Model for Evaluating Therapies Directed Against Radiation-Induced Lung DamageRadiation Research, 2011
- Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant miceJournal of Hematology & Oncology, 2009
- Cytokine Plasma Levels: Reliable Predictors for Radiation Pneumonitis?PLOS ONE, 2008
- Molecular markers of radiation-related normal tissue toxicityCancer and Metastasis Reviews, 2008
- HEALTH EFFECTS IN THOSE WITH ACUTE RADIATION SICKNESS FROM THE CHERNOBYL ACCIDENTHealth Physics, 2007
- Predicting Risk of Radiation-Induced Lung InjuryJournal of Thoracic Oncology, 2007
- Plasma transforming growth factor β1 as a predictor of radiation pneumonitisInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systemsInternational Journal of Radiation Oncology*Biology*Physics, 1995